Registry for patients with left ventricular thrombus

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on patients with left ventricular thrombus (LVT), a condition where blood clots form in the heart's main chamber, often following a heart attack or in cases of heart failure. By collecting information on patient demographics, clinical factors, and quality of life, the study seeks to enhance understanding of LVT formation and management. Participants will have their blood and scan results recorded, and may complete a quality of life questionnaire during routine MRI scans. The ultimate goal is to improve treatment strategies for LVT and reduce associated complications such as stroke.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with LV thrombus or;
* Patients at risk for developing LV thrombus (e.g severe LV dysfunction, LV aneurysm, MI.

Exclusion Criteria:

* Age \< 18 years
* Unable to consent

Where it's running

• Royal Papworth Hospital
  Cambridge, Cambridgeshire, United Kingdom Recruiting
• Lancashire Cardiac Centre
  Blackpool, United Kingdom Recruiting
• Leeds General Infirmary
  Leeds, United Kingdom Recruiting
• St Bartholomew's Hospital
  London, United Kingdom Recruiting
• Imperial College Healthcare London
  London, United Kingdom Recruiting
• Basildon University Hospital
  London, Essex, United Kingdom Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Apixaban vs Warfarin for a Left Ventricular Thrombus

  This study tests whether apixaban can more conveniently and safely dissolve a left ventricular blood clot compared with warfarin.

  Recruiting Phase 3 University of Arizona · Tucson, Arizona · NCT07709780

• Using Apixaban to prevent blood clots after heart attacks

  This study is testing if a low dose of Apixaban can help prevent blood clots in people who have had a heart attack and have weak heart function.

  Recruiting Phase 3 National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh · NCT06742567

• Apixaban versus warfarin for left ventricular clot after a heart attack

  This compares apixaban and warfarin to see which better clears left-ventricular blood clots in adults after a heart attack.

  Recruiting at 3 sites Phase 4 Karolinska Institutet · Falun and 15 other locations · NCT06515730

• Anticoagulation After a Heart Attack with Left Ventricular Clot

  This study tests whether adding rivaroxaban to standard dual antiplatelet therapy helps people who develop a left ventricular thrombus after a STEMI.

  Recruiting Jilin University · Changchun, Jilin · NCT05892042

• Comparing anticoagulants for treating left ventricular thrombus after heart attacks in Nepal

  This study is testing whether two blood-thinning medications, Rivaroxaban and Warfarin, can help people in Nepal with blood clots in the heart after a heart attack.

  Recruiting Phase 4 Shahid Gangalal National Heart Centre · Kathmandu, Bagmati · NCT05794399

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.